Diplomat Announces 3rd Quarter Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
Go back to Diplomat Announces 3rd Quarter Financial Results
November 3, 2016 7:42 AM EDT
Avondale Partners downgraded Diplomat Pharmacy (NYSE: DPLO) from Market Outperform to Market Perform.
For an analyst ratings summary and ratings history on Diplomat Pharmacy click here. For more ratings news on Diplomat Pharmacy click here.
Shares of Diplomat Pharmacy closed at $22.38 yesterday.
...
More
November 3, 2016 6:59 AM EDT
Leerink Partners downgraded Diplomat Pharmacy (NYSE: DPLO) from Outperform to Market Perform with a price target of $18.00 (from $35.00).
Analyst David Larsen commented, "Yesterday afternoon DPLO reduced its outlook for 2016 and provided a preliminary outlook for 2017 that was well below expectations. As a... More
November 2, 2016 5:16 PM EDT
Diplomat Pharmacy (NYSE: DPLO) reported Q3 EPS of $0.21, $0.03 worse than the analyst estimate of $0.24. Revenue for the quarter came in at $1.18 billion versus the consensus estimate of $1.26 billion.
GUIDANCE:
Diplomat Pharmacy sees FY2016 EPS of $0.83-$0.87, versus the consensus of... More
